The Effects of Seasonal Changes in Osteoporosis Treatment
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Effects of raloxifene on bone mineral density in postmenopausal osteoporosis.
研究概览
简要总结
There are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons.
详细描述
Vitamin D insufficiency is common in many countries. Vitamin D insufficiency is associated with osteoporosis and the responses to osteoporosis treatment. 25-hydroxyvitamin D (25OHD) is considered to be the best estimate of body stores of vitamin D and the seasonal variation of 25OHD is well known. But there are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons in patients treated by raloxifene.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 45 Years 至 100 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Postmenopausal women
排除标准
- •Patients who could not use SERM
结局指标
主要结局
Effects of raloxifene on bone mineral density in postmenopausal osteoporosis.
时间窗: Up to 36 months
次要结局
未报告次要终点
研究者
Toshihiko Kono
Head of Hospital
Tomidahama Hospital